Increasing mixed chimerism predicts relapse in childhood acute myelogenous leukemias after allogeneic stem cell transplantation which can be prevented by immunomodulatory regimens

被引:0
|
作者
Bader, P
Kreyenberg, H
Hoelle, W
Dueckers, G
Lang, P
Niethammer, D
Klingebiel, T
Beck, JF
机构
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S124 / S124
页数:1
相关论文
共 50 条
  • [31] Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia
    Kantarjian, HM
    O'Brien, S
    Cortes, JE
    Giralt, SA
    Rios, MB
    Shan, JQ
    Giles, FJ
    Thomas, DA
    Faderl, S
    De Lima, M
    Garcia-Manero, G
    Champlin, R
    Arlinghaus, R
    Talpaz, M
    BLOOD, 2002, 100 (05) : 1590 - 1595
  • [32] Chimerism on 30 day after allogeneic hematopoietic stem cell transplantation predicts early relapses
    Lavrinenko, V.
    Mareiko, Y.
    Berezovskaya, E.
    Belevtsev, M.
    Bydanov, O.
    Aleynikova, O.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S451 - S452
  • [33] Transient mixed chimerism after stem cell transplantation can induce durable molecular complete remissions in chronic myelogenous leukemia
    Ruiz-Argueelles, Guillermo J.
    Gomez-Almaguer, David
    Ruiz-Delgado, Guillermo J.
    Tarin-Arzaga, Luz Del C.
    LEUKEMIA & LYMPHOMA, 2006, 47 (12) : 2590 - 2592
  • [34] The predictive value of T-cell chimerism for disease relapse after allogeneic hematopoietic stem cell transplantation
    Li, Zhipeng
    Wang, Jing
    Deng, Lei
    Liu, Ximin
    Kong, Fanjun
    Zhao, Yuerong
    Hou, Yixi
    Zhou, Fang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [35] Prevention of relapse by donor lymphocyte infusion for mixed chimerism 7 months after T-cell depleted allogeneic stem cell transplantation
    Marijt, W.
    Baas, I.
    von dem Borne, P.
    Barge, R.
    Deutz, P.
    Beaumont, F.
    Starrenburg, I.
    Fibbe, W.
    Willemze, R.
    Falkenburg, J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S161 - S161
  • [36] DONOR LYMPHOCYTE INFUSION FOR MIXED CHIMERISM AT 7 MONTHS AFTER T CELL DEPLETED ALLOGENEIC STEM CELL TRANSPLANTATION REDUCES RELAPSE RISK
    Marijt, W. A.
    von dem Borne, A.
    Barge, M. Y.
    Deutz-Terlouw, P.
    Beaumont, M.
    Starrenburg, C. W. J.
    Fibbe, E.
    Willemze, R.
    Falkenburg, J. H. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 241 - 241
  • [37] Intensified pre-emptive immunotherapy in childhood acute myeloid leukaemia patients showing evidence of mixed chimerism after allogeneic stem cell transplantation
    Rettinger, E.
    Willasch, A.
    Kreyenberg, H.
    Borkhardt, A.
    Holter, W.
    Kremens, B.
    Strahm, B.
    Woessmann, W.
    Mauz-Koerholz, C.
    Gruhn, B.
    Burdach, S.
    Albert, M.
    Schlegel, P. -G.
    Klingebiel, T.
    Bader, P.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S16 - S16
  • [38] Early Lymphoid Subsets Reconstitution after Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) as Predictor of Relapse and Survival in Acute Leukemias
    Boncompagni, Riccardo
    Fani, Arianna
    Cutini, Ilaria
    Ciolli, Gaia
    Innocenti, Chiara
    Di Gioia, Massimo
    Mariotti, Serena
    Guarrera, Agata Suellen
    Raugei, Giulia
    Gozzini, Antonella
    Nozzoli, Chiara
    Guidi, Stefano
    Saccardi, Riccardo
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 542 - 543
  • [39] Molecular monitoring of mixed chimerism early after allogeneic stem cell transplantation may predict the occurrence of acute GvHD
    Jaksch, M
    Uzunel, M
    Remberger, M
    Sundberg, B
    Mattsson, J
    BONE MARROW TRANSPLANTATION, 2004, 33 : S310 - S311
  • [40] Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT
    Bader, P
    Beck, J
    Frey, A
    Schlegel, PG
    Hebarth, H
    Handgretinger, R
    Einsele, H
    Niemeyer, C
    Benda, N
    Faul, C
    Kanz, L
    Niethammer, D
    Klingebiel, T
    BONE MARROW TRANSPLANTATION, 1998, 21 (05) : 487 - 495